Research Papers:
Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1548 views | HTML 2262 views | ?
Abstract
Fei Zhou1,2,3,*, Lei Cheng1,2,*, Li-Xin Qiu1,2, Meng-Yun Wang1,2, Jin Li2, Meng-Hong Sun4, Ya-Jun Yang5,6, Jiu-Cun Wang5,6, Li Jin5,6, Ya-Nong Wang7, Qing-Yi Wei1,8
1Cancer Institute, Collaborative Innovation Center for Cancer Medicine, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
3Department of Oncology, Shanghai Jiaotong University Affiliated Shanghai First People’s Hospital, Shanghai 20080, China
4Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
5Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China
6Fudan-Taizhou Institute of Health Sciences, Taizhou, Jiangsu 225300, China
7Department of Gastric Cancer & Soft Tissue Sarcoma Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
8Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA
*These authors have contributed equally to this work
Correspondence to:
Ya-Nong Wang, e-mail: [email protected]
Qing-Yi Wei, e-mail: [email protected], [email protected]
Keywords: interleukin-6/JAK/STAT3, signaling pathway, genetic variate, gastric cancer, genetic susceptibility
Received: December 08, 2015 Accepted: March 14, 2016 Published: March 30, 2016
ABSTRACT
The interleukin-6 (IL-6)/JAK/STAT3 signaling pathway plays a central role in inflammation-mediated cancers, including gastric cancer (GCa). We evaluated associations between 10 potentially functional single nucleotide polymorphisms (SNPs) of four essential genes in the pathway and GCa risk in a study of 1,125 GCa cases and 1,221 cancer-free controls. We found that a significant higher GCa risk was associated with IL-6 rs2069837G variant genotypes [adjusted odds ratios (OR) = 1.33; 95% confidence interval (CI) = 1.12-1.59 for AG + GG vs. AA)] and JAK1 rs2230587A variant genotypes (adjusted OR = 1.20; 95% CI = 1.02-1.43 for GA + AA vs. GG). We also found that a significant decreased GCa risk was associated with STAT3 rs1053004G variant genotypes (adjusted OR = 0.84; 95% CI = 0.71-0.99 for AG + GG vs. AA). The combined analysis of IL-6 rs2069837G and JAK1 rs2230587A variant risk genotypes revealed that individuals with one-or-two risk genotypes exhibited an increased risk for GCa (adjusted OR = 1.34; 95% CI = 1.13-1.59). Genotypes and mRNA expression correlation analysis using the data from the HapMap 3 database provided further support for the observed risk associations. Larger studies are warranted to validate these findings.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8492